IBB vs VAW

iShares Biotechnology ETF vs Vanguard Materials ETF

Quick take
  • VAW has the lower expense ratio at 0.09% vs 0.44% for IBB.
  • VAW pays a higher dividend yield (1.37%).

Side-by-side metrics

MetricIBBVAW
Expense ratio
Annual fee. Lower is better.
0.44%0.09%
Dividend yield
Trailing 12-month yield.
0.23%1.37%
AUM
Assets under management — bigger funds are typically more liquid.
$7.95B$4.54B
YTD return
3.10%14.25%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.741.02
P/E ratio
23.7225.98
Last price
$170.10$232.03
Inception
Issuer
iSharesVanguard

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

VAW top holdings

Top holdings · VAW
LINLinde PLC15.14%
NEMNewmont Corp7.73%
FCXFreeport-McMoRan Inc5.52%
SHWSherwin-Williams Co4.94%
CRHCRH PLC4.61%
ECLEcolab Inc4.44%
APDAir Products and Chemicals Inc4.05%
CTVACorteva Inc3.70%
NUENucor Corp2.53%
VMCVulcan Materials Co2.35%
Sector breakdown · VAW
Consumer Cyclical9.2%
Basic Materials89.3%
Consumer Defensive0.0%
Industrials0.9%
Healthcare0.5%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About VAW

VAW (Vanguard Materials ETF) is US materials sector stocks. Managed by Vanguard, the fund carries $4.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.37%. Its largest holding is Linde PLC (LIN), which represents 15.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.2%.